Bruker vs Globus Medical
Bruker (BRKR), health care, and Globus Medical (GMED), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Bruker and Globus Medical are valued at about the same: $9.4B and $9.3B. Bruker's operating margin in its latest fiscal year was 1.98% and Globus Medical's 16.3%. Over the past year Bruker's share price has moved +42.1% and Globus Medical's -15.5%.
Key facts
- Bruker market value
- $9.4B
- Globus Medical market value
- $9.3B
- Globus Medical P/E
- 17.4
- Bruker revenue
- $3.4BFY to 2025-12-31
- Globus Medical revenue
- $2.9BFY to 2025-12-31
- Superinvestors holding both
- 1
Market values as of .
| Measure | Bruker | Globus Medical |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $9.4Bhigher | $9.3Blower |
| Revenue | $3.4Bhigher | $2.9Blower |
| Earnings | -$8.6Mlower | $537.9Mhigher |
| Employees | 11,085higher | 6,000lower |
| Total assets | $6.2Bhigher | $5.3Blower |
| Valuation | ||
| P/E | — | 17.4 |
| P/S | 2.7lower | 3.2higher |
| P/B | 4.1higher | 1.9lower |
| Dividend yield | 0.08%higher | 0.00%lower |
| Profitability | ||
| Operating margin | 1.98%lower | 16.3%higher |
| Balance sheet | ||
| Net assets | $2.5Blower | $4.6Bhigher |
| Total liabilities | $3.7Bhigher | $729.5Mlower |
| Total debt | $1.9B | — |
| Cash on hand | $298.8Mlower | $526.2Mhigher |
| Price change | ||
| Today | +1.22%higher | -0.72%lower |
| 1 year | +42.1%higher | -15.5%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (1)
- Jeremy Grantham (co-founder)0.1% / 0.1%
Bruker only (3)
- Robert Pitts1.2%
- Larry Robbins0.3%
- Andreas Halvorsen0.2%
Globus Medical only (2)
Percentages are each holding's share of that investor's reported portfolio (under "Both": Bruker / Globus Medical). Who owns BRKR · Who owns GMED
More on Bruker
Further comparisons
Bruker against its closest peers
Globus Medical against its closest peers
Learn
Questions and answers
Which is bigger, Bruker or Globus Medical?
By market value, Bruker is the larger: $9.4B against $9.3B for Globus Medical. By revenue in its latest fiscal year, Bruker is the larger: $3.4B against $2.9B for Globus Medical.
Which has the higher operating margin?
Globus Medical: 16.3%, against 1.98% for Bruker. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Bruker: 0.08%, against 0.00% for Globus Medical. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which superinvestors own both Bruker and Globus Medical?
In their latest 13F filings, Jeremy Grantham (co-founder) holds both.
Cite this page
Funkfolio, “Bruker vs Globus Medical”, data as of 18 November 2026. https://funkfolio.com/compare/brkr-vs-gmed
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.